ATH
Price sensitive
Alterity Receives Positive FDA Feedback From Type C Meeting
Alterity Therapeutics Ltd
No summary is available for this announcement — open the PDF to read it in full.
Sign in for more about this company, including guidance changes and other insights.
Sign in